© 2018 TripleMed   • All rights reserved  • Design by Brightlands Maastricht Health Campus 
TripleMed
Oxfordlaan 70 
6229EV Maastricht
The Netherlands

Mission & Vision

Develop Safe & (Cost)-Effective minimally invasive solutions for Aortic Aneurysms.

Mission

Vision

Since 2000 the treatment of Abdominal Aortic Aneurysms has been revolutionized with the introduction of the EVAR endograft. The first endografts demonstrated a large reduction in mortality in the early phase, during and after the procedure. Unfortunately, this benefit over the existing open-surgery solution is largely lost after 5-7 years due to a higher rate of complications and subsequent reinterventions. Over the years, improved endograft designs have reduced the rate of complications, but still do not show the level of durability that can be obtained with open-surgery. It is our belief that via the use of a stable in-situ implant, which completely fills the aneurysm sac, the same durability can be achieved as with open-surgery, and thus the final step of the revolution from open-surgery to a percutaneous endovascular procedure can be realized.